UNVERIFIEDSingle Source
Opinion: STAT+: Landmines await Vinay Prasad’s successor at the FDA
Stat News|4/13/2026
F
Fda
337 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
187
Activity (Last 30 Days)
3
6
4
2
1
2
2
2
2
4
7
1
1
3
1
1
2
2
2
1
2026-03-172026-04-15
Top Publishers
Stat News78 stories
Google News26 stories
Ars Technica10 stories
WSJ9 stories
NPR6 stories
Stories (Latest First)
UNVERIFIEDSingle Source
GAO report shows gap between scale of illegal vapes and enforcement
Stat News|4/10/2026
UNVERIFIEDSingle Source
STAT+: Replimune skin cancer drug that became FDA flashpoint is rejected again
Stat News|4/10/2026
UNVERIFIEDSingle Source
Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review
Stat News|4/7/2026
UNVERIFIEDSingle Source
FDA’s evolving view of what makes a ‘breakthrough’ device
statnews.com|4/2/2026
UNVERIFIEDSingle Source
STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Stat News|4/2/2026
UNVERIFIEDSingle Source
STAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest
Stat News|4/1/2026
UNVERIFIEDSingle Source
FDA sees promise in voice-based AI model for heart failure
Cardiovascular Business|3/27/2026
UNVERIFIEDSingle Source
STAT+: Amid focus on food, FDA leader briefs lawmakers on priorities
Stat News|3/27/2026
UNVERIFIEDSingle Source
STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era
Stat News|3/19/2026
UNVERIFIEDSingle Source
Nia Therapeutics wins FDA breakthrough nod for neuromod that treats memory loss
MassDevice|3/18/2026
UNVERIFIEDSingle Source
Radiology Partners’ AI business receives Breakthrough Device designation from FDA
Radiology Business|3/9/2026
UNVERIFIEDSingle Source
Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: The extremism of the FDA’s Marks and Prasad has come with costs
Stat News|3/5/2026
UNVERIFIEDSingle Source
STAT+: Prime Medicine to seek approval for gene editing treatment after two-patient trial
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: UniQure plans to seek approval for Huntington’s therapy still blocked by FDA
Stat News|3/2/2026
UNVERIFIEDSingle Source
Brain implants: What’s standing in the way of pivotal trials, FDA approval
Stat News|2/26/2026
UNVERIFIEDSingle Source
Opinion | A Welcome FDA Walkback on a Flu Vaccine
The Wall Street Journal|2/22/2026
UNVERIFIEDSingle Source
Opinion | A Welcome FDA Walkback on a Flu Vaccine
The Wall Street Journal|2/22/2026
UNVERIFIEDSingle Source
Opinion | A Welcome FDA Walkback on a Flu Vaccine
The Wall Street Journal|2/22/2026
UNVERIFIEDSingle Source
FDA wants to make more drugs available over the counter, but experts have raised safety concerns
Scientific American|2/20/2026
UNVERIFIEDSingle Source
Biohackers and wellness influencers are pushing nicotine as part of their ‘stacks’
Stat News|2/20/2026
UNVERIFIEDSingle Source
The FDA Talks Over-the-Counter Freedom. Big Pharma Profits From Keeping It Restricted.
Reason Magazine|2/19/2026
UNVERIFIEDSingle Source
FDA's reversal on Moderna flu shot bid followed White House pressure
Politico|2/18/2026
UNVERIFIEDSingle Source
STAT+: New FDA guidance for antibiotic use in food-producing animals prompts criticism over antibiotic resistance
Stat News|2/18/2026
UNVERIFIEDSingle Source
Opinion | The FDA’s damage to medical innovation will be hard to repair
The Washington Post|2/18/2026
UNVERIFIEDSingle Source
FDA does U-turn, will review Moderna's mRNA flu shot after shocking rejection
Ars Technica|2/18/2026
UNVERIFIEDSingle Source
FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal
Scientific American|2/18/2026
UNVERIFIEDSingle Source
Why the FDA is cracking down on compound GLP-1 drugs for weight loss
Scientific American|2/18/2026
UNVERIFIEDSingle Source
STAT+: At drugmakers’ forum, Oz gets a friendly embrace, while Makary faces tough questions
Stat News|2/17/2026
UNVERIFIEDSingle Source
Opinion: When IV opioids are in short supply at the hospital, who gets pain relief?
Stat News|2/17/2026
UNVERIFIEDSingle Source
STAT+: FDA’s rejection of Moderna threatens to stifle broader vaccine industry
Stat News|2/12/2026
UNVERIFIEDSingle Source
Hims & Hers abandons copycat weight-loss drug in face of FDA probe
Financial Times|2/7/2026
UNVERIFIEDSingle Source
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
Stat News|2/7/2026
UNVERIFIEDSingle Source
STAT+: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy
Stat News|2/2/2026
UNVERIFIEDSingle Source
AI-designed NLRP3 inhibitor receives FDA clearance for Parkinson disease trials
News-Medical|1/24/2026
UNVERIFIEDSingle Source
Legal questions swirl around FDA's new expedited drug program, including who should sign off - Yahoo
Google News|1/16/2026
UNVERIFIEDSingle Source
FDA deletes warning on bogus autism therapies touted by RFK Jr.‘s allies - Ars Technica
Google News|1/13/2026
UNVERIFIEDSingle Source
Pazdur warns that politics, ‘chaos’ are damaging FDA - statnews.com
Google News|1/13/2026
UNVERIFIEDSingle Source
‘She has no expertise’: the US medical community girds for Tracy Beth Høeg’s tenure at the FDA
The Guardian|12/31/2025
UNVERIFIEDSingle Source
FDA announces recalls of sweet treats 2 days before Christmas - NewsNation
Google News|12/24/2025
UNVERIFIEDSingle Source
FDA OKs libido-boosting pill for women who have gone through menopause - CNN
Google News|12/15/2025
UNVERIFIEDSingle Source
FDA OKs libido-boosting pill for women who have gone through menopause - AP News
Google News|12/15/2025